CORDIS · 213631 · FP7
NANOTHER Integration of Novel Nanoparticle based Technology for Therapeutics and Diagnosis of different types of Cancer
Coordinator: FUNDACION GAIKER (ES)
The breakthrough objective of NANOTHER is to develop & characterise a novel nanoparticle system that will be used as a therapeutic agent or diagnosis tool for breast cancer, colorectal cancer & bone metastasis. Theranostics, the development of nanoparticles with both functionalities, will also be carried out using the hyperthermic effect to kill tumour cells or to release the selected drug . The nanoparticles used in NANOTHER will be selected based on previous studies. Therefore, only polymeric micelles core-shell nanoparticles and magnetic nanoparticles will be included in the study. The nan…
About Seventh Framework Programme (2007–2013)
The Seventh Framework Programme (FP7) ran from 2007 to 2013 and was the EU's main research-funding instrument of that period. It mobilised roughly €50 billion across cooperation projects, ERC frontier grants, Marie Curie fellowships, capacity-building actions and Euratom research. FP7 closed to new calls in 2013 but its projects continued for years after under their original grant agreements.
EU contribution: €8.4M awarded to the consortium. The project runs over approximately 4 years from 2008-09-01 to 2012-08-31.
Full record on CORDIS — partners, deliverables, publications, news.
Open on cordis.europa.eu →More from ES
see all →- EITUM-BP26-28 — EIT Urban Mobility Business Plan 2026-2028101269525 · HORIZON · €206.9M
- ERA4TB — EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS853989 · H2020 · €89.8M
- DRIVER+ — DRiving InnoVation in crisis management for European Resilience607798 · FP7 · €33.5M
- READI — Research in Europe and Diversity Inclusion101166227 · HORIZON · €31.5M
- GREENH2ATLANTIC — A 100 MW FLEXIBLE GREEN HYDROGEN PRODUCTION PROCESS SOURCING HYBRID RENEWABLE ENERGY AND SUPPLYING GREEN HYDROGEN TO MULTIPLE END-USES101036908 · H2020 · €30.0M
- PERSEUS — Protection of European seas and borders through the intelligent use of surveillance261748 · FP7 · €27.8M
Other FP7 projects
see all →- COST II — Provision of Scientific, Technical and Administrative Management of COST200443 · FR · €250.0M
- COMBACTE-NET — Combatting Bacterial Resistance in Europe115523 · SE · €109.4M
- EUC²LID — European Lead Factory115489 · DE · €80.0M
- COMBACTE-MAGNET — Combatting Bacterial Resistance in Europe - Molecules against Gram Negative Infections115737 · SE · €75.3M
- ENABLE — European Gram Negative Antibacterial Engine115583 · UK · €58.9M
- PLACES2BE — Pilot Lines for Advanced CMOS EmbodimentS in 2x nodes, Built in Europe325633 · FR · €52.6M
Frequently asked questions
- Who funds this research project?
- This project is funded by the European Union through the Seventh Framework Programme (2007–2013) programme, under the CP-IP funding scheme.
- What is the EU contribution?
- The European Commission contributes €8.4M.
- Which EU programme funds it?
- The project is funded under Seventh Framework Programme (2007–2013).
- Who coordinates the project?
- The project is coordinated by FUNDACION GAIKER (ES).
- What is the project timeline?
- The project runs from 2008-09-01 to 2012-08-31 — approximately 4 years.
- Where can I find the full project record?
- The complete record — partners, deliverables, publications and news — is published on CORDIS under project ID 213631.